Nitrimidazine (Naxogin) compared with metronidazole (Flagyl) (Rodin, King, Nicol, and Barrow, 1960) . In a recent trial it was shown that a 5-day course of 400 mg. twice daily produced equally satisfactory results, and was probably an easier regime from the patient's point of view (McClean, 1971) .
Nitrimidazine (Naxogin) is a related compound introduced in Italy for treatment of the same condition, and equally satisfactory or better results are claimed for it when used at a dosage of 250 mg. twice daily for 6 days (Emanueli and de Carneri, 1969; Signorelli and Emanueli, 1969) .
In the trial to be described the two compounds were compared in the treatment of trichomoniasis in women, the 5-day regime being used in the case of metronidazole, and the standard 6-day regime for nitrimidazine.
Material and methods
The trial, which was carried out in the Lydia Clinic at St. Thomas's Hospital, involved 100 patients presenting with new infections with T. vaginalis. Their marital status is shown in Table I . Diagnosis was based on findings in wet vaginal smears or results of culture in Feinberg-Whittington medium. Five follow-up examinations over 3 months were aimed for, including at least one examination by culture. Concurrent infections were diagnosed, treated, and followed up, for the same length of time in the usual manner.
AGE
Of the 100 patients, 84 were aged 18 to 35 years, six were younger (all post-pubescent), and ten were older.
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Fifty women received 400 mg. metronidazole twice daily for 5 days and fifty received nitrimidazine 250 mg. twice daily for 6 days. Records were made of further sexual intercourse during the trial period and of symptoms suggesting side-effects.
Results
Of the fifty patients treated with metronidazole, five (10 per cent.) failed to return, and of the fifty treated with nitrimidazine, eleven (22 per cent.) defaulted, and one took only four tablets. These patients were excluded from the trial, leaving a total of 45 in the first group and 38 in the second. The duration of follow-up is shown in Table II (Table III) . Four patients complained of side-effects with Flagyl (one depression, one headaches, and two nausea). Two patients complained of side-effects with Naxogin (one depression and nausea and one vertigo). In none of these was it necessary to stop administration of either drug.
The cases of treatment failure (or re-infection) are analysed in Table IV , which shows the interval between treatment and the reappearance of T. vaginalis and whether the patient admitted further sexual intercourse. In both groups, several cases of recurrence attributed to treatment failure may well have been due to re-infection. 
